[开放获取]    皮肤基底细胞癌诊疗专家共识（2021）

doi:10.35541/cjd.20201139

Abstract

Abstract: 【Abstract】 Basal cell carcinoma （BCC） is the most common malignant skin tumor. It is slow-growing and less likely to metastasize, but the high-risk subtype can destroy tissues and organs, and even endanger patients′ lives. Based on the recent domestic and international literature and guidelines, and combining with the current status of diagnosis and treatment of BCC in China and multidisciplinary expert opinions, this article focuses on clinical manifestations, diagnosis, risk assessment and treatment of cutaneous BCC, aiming to form an expert consensus on the diagnosis and treatment of cutaneous BCC in China and provide a reference for standardized diagnosis and treatment in clinical practice.

Key words: Carcinoma, basal cell, Diagnosis, Treatment, Expert consensus

Skin Tumor Research Center, Chinese Society of Dermatology, Subcommittee on Skin Tumor, China Dermatologist Association. Expert consensus on diagnosis and treatment of cutaneous basal cell carcinoma （2021）[J]. Chinese Journal of Dermatology, 2021, 54(9): 757-764.doi:10.35541/cjd.20201139

References ［39］

［1］	Peris K, Fargnoli MC, Garbe C, et al. Diagnosis and treatment of basal cell carcinoma: European consensus⁃based interdisciplinary guidelines［J］. Eur J Cancer, 2019,118:10⁃34. doi: 10.1016/j.ejca.2019.06.003.
［2］	Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016［J］. Lancet, 2018,391（10136）:2236⁃2271. doi: 10.1016/S0140⁃6736（18）30994⁃2.
［3］	Wu S, Han J, Li WQ, et al. Basal⁃cell carcinoma incidence and associated risk factors in U.S. women and men［J］. Am J Epidemiol, 2013,178（6）:890⁃897. doi: 10.1093/aje/kwt073.
［4］	涂庆峰, 吕婷, 赖永贤, 等. 上海市某社区老年人皮肤肿瘤流行病学研究［J］. 老年医学与保健, 2013,19（3）:142⁃145,148. doi: 10.3969/j.issn.1008⁃8296.2013⁃05.
［5］	郑博文, 邹勇莉, 何黎, 等. 皮肤恶性肿瘤568例回顾性分析［J］. 中国皮肤性病学杂志, 2009,23（12）:808⁃809,818.
［6］	黄远深, 李航, 涂平, 等. 632例皮肤恶性肿瘤及癌前病变临床分析［J］. 中华皮肤科杂志, 2010,43（7）:452⁃454. doi: 10. 3760/cma.j.issn.0412⁃4030.2010.07.002.
［7］	陈娜, 张良, 陈柳青. 皮肤恶性肿瘤及癌前病变3163例临床分析［J］. 临床皮肤科杂志, 2020,49（8）:456⁃459. doi: 10. 16761/j.cnki.1000⁃4963.2020.08.004.
［8］	陈自学, 周美杉, 涂平, 等. 418例基底细胞癌病例临床病理特点回顾分析［J］. 北京大学学报（医学版）, 2014,46（2）:195⁃199. doi: 10.3969/j.issn.1671⁃167X.2014.02.004.
［9］	高蓉梅. 109例皮肤基底细胞癌临床病理特点分析［J］. 医药前沿, 2018,8（3）:74⁃75.
［10］	McKenzie CA, Chen AC, Choy B, et al. Classification of high risk basal cell carcinoma subtypes: experience of the ONTRAC study with proposed definitions and guidelines for pathological reporting［J］. Pathology, 2016,48（5）:395⁃397. doi: 10.1016/j.pathol.2016.05.005.
［11］	Zanetti R, Rosso S, Martinez C, et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi⁃centre case⁃case⁃control study［J］. Br J Cancer, 2006,94（5）:743⁃751. doi: 10.1038/sj.bjc.6602982.
［12］	Bonilla X, Parmentier L, King B, et al. Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma［J］. Nat Genet, 2016,48（4）:398⁃406. doi: 10. 1038/ng.3525.
［13］	Jayaraman SS, Rayhan DJ, Hazany S, et al. Mutational landscape of basal cell carcinomas by whole⁃exome sequencing［J］. J Invest Dermatol, 2014,134（1）:213⁃220. doi: 10.1038/jid.2013.276.
［14］	Bresler SC, Padwa BL, Granter SR. Nevoid basal cell carcinoma syndrome （Gorlin syndrome）［J］. Head Neck Pathol, 2016,10（2）:119⁃124. doi: 10.1007/s12105⁃016⁃0706⁃9.
［15］	AlSabbagh MM, Baqi MA. Bazex⁃Dupré⁃Christol syndrome: review of clinical and molecular aspects［J］. Int J Dermatol, 2018,57（9）:1102⁃1106. doi: 10.1111/ijd.14065.
［16］	中国中西医结合学会皮肤性病专业委员会皮肤影像学组, 中国医疗保健国际交流促进会皮肤科分会皮肤影像学组, 中华医学会皮肤性病学分会皮肤病数字化诊断亚学组, 等. 中国基底细胞癌皮肤镜特征专家共识（2019）［J］. 中华皮肤科杂志, 2019,52（6）:371⁃377. doi: 10.3760/cma.j.issn.0412⁃4030. 2019.06.001.
［17］	中华医学会皮肤性病学分会皮肤肿瘤研究中心, 中国医师协会皮肤科医师分会皮肤肿瘤学组. 皮肤鳞状细胞癌规范化诊疗共识（2021）［J］. 中华皮肤科杂志, 2021,54（8）:653⁃664. doi: 10.35541/cjd.20201140.
［18］	National Comprehensive Cancer Network. Basal cell skin cancer, version 2.2021, NCCN clinical practice guidelines in oncology［Z/OL］. （2021⁃02⁃25）［2021⁃07⁃01］. https://www.nccn.org/professionals/physician_gls/pdf/nmsc.pdf.
［19］	Tanese K. Diagnosis and management of basal cell carcinoma［J］. Curr Treat Options Oncol, 2019,20（2）:13. doi: 10.1007/s11864⁃019⁃0610⁃0.
［20］	Smeets NW, Krekels GA, Ostertag JU, et al. Surgical excision vs Mohs′ micrographic surgery for basal⁃cell carcinoma of the face: randomised controlled trial［J］. Lancet, 2004,364（9447）:1766⁃1772. doi: 10.1016/S0140⁃6736（04）17399⁃6.
［21］	Van Loo E, Mosterd K, Krekels GA, et al. Surgical excision versus Mohs′ micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow⁃up［J］. Eur J Cancer, 2014,50（17）:3011⁃3020. doi: 10.1016/j.ejca.2014. 08.018.
［22］	Mosterd K, Krekels GA, Nieman FH, et al. Surgical excision versus Mohs′ micrographic surgery for primary and recurrent basal⁃cell carcinoma of the face: a prospective randomised controlled trial with 5⁃years′ follow⁃up［J］. Lancet Oncol, 2008,9（12）:1149⁃1156. doi: 10.1016/S1470⁃2045（08）70260⁃2.
［23］	李媛媛, 池丽俏. 手术切除治疗皮肤恶性肿瘤的效果与复发率分析［J］. 中国肿瘤临床与康复, 2020,27（5）:575⁃578. doi: 10.13455/j.cnki.cjcor.2020.05.17.
［24］	王彦. 慢Mohs显微外科手术治疗皮肤基底细胞癌的临床观察［J］. 中国医疗美容, 2019,9（7）:39⁃42. doi: 10.19593/j.issn.2095⁃0721.2019.07.010.
［25］	Tchanque⁃Fossuo CN, Eisen DB. A systematic review on the use of cryotherapy versus other treatments for basal cell carcinoma［J］. Dermatol Online J, 2018, 24（11）. doi: 10.5070/D32411042000.
［26］	Bath⁃Hextall F, Ozolins M, Armstrong SJ, et al. Surgical excision versus imiquimod 5% cream for nodular and superficial basal⁃cell carcinoma （SINS）: a multicentre, non⁃inferiority, randomised controlled trial［J］. Lancet Oncol, 2014,15（1）:96⁃105. doi: 10. 1016/S1470⁃2045（13）70530⁃8.
［27］	Ferreres JR, Macaya A, Jucgla A, et al. Hundreds of basal cell carcinomas in a Gorlin⁃Goltz syndrome patient cured with imiquimod 5% cream［J］. J Eur Acad Dermatol Venereol, 2006,20（7）:877⁃878. doi: 10.1111/j.1468⁃3083.2006.01552.x.
［28］	Miller BH, Shavin JS, Cognetta A, et al. Nonsurgical treatment of basal cell carcinomas with intralesional 5⁃fluorouracil/epinephrine injectable gel［J］. J Am Acad Dermatol, 1997,36（1）:72⁃77. doi: 10.1016/s0190⁃9622（97）70328⁃1.
［29］	Kowalzick L, Rogozinski T, Wimheuer R, et al. Intralesional recombinant interferon beta⁃1a in the treatment of basal cell carcinoma: results of an open⁃label multicentre study［J］. Eur J Dermatol, 2002,12（6）:558⁃561.
［30］	Kaplan B, Moy RL. Effect of perilesional injections of PEG⁃interleukin⁃2 on basal cell carcinoma［J］. Dermatol Surg, 2000, 26（11）:1037⁃1040. doi: 10.1046/j.1524⁃4725.2000.0260111037.x.
［31］	Glass LF, Jaroszeski M, Gilbert R, et al. Intralesional bleomycin⁃mediated electrochemotherapy in 20 patients with basal cell carcinoma［J］. J Am Acad Dermatol, 1997,37（4）:596⁃599. doi: 10.1016/s0190⁃9622（97）70178⁃6.
［32］	Wang H, Xu Y, Shi J, et al. Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta⁃analysis［J］. Photodermatol Photoimmunol Photomed, 2015,31（1）:44⁃53. doi: 10.1111/phpp.12148.
［33］	任媛, 王元元, 张军波, 等. 局部光动力疗法治疗皮肤恶性肿瘤的远期疗效评价［J］. 重庆医学, 2017,46（10）:1373⁃1374. doi: 10.3969/j.issn.1671⁃8348.2017.10.025.
［34］	Soleymani T, Abrouk M, Kelly KM. An analysis of laser therapy for the treatment of nonmelanoma skin cancer［J］. Dermatol Surg, 2017,43（5）:615⁃624. doi: 10.1097/DSS.0000000000001048.
［35］	Migden MR, Chang A, Dirix L, et al. Emerging trends in the treatment of advanced basal cell carcinoma［J］. Cancer Treat Rev, 2018,64:1⁃10. doi: 10.1016/j.ctrv.2017.12.009.
［36］	von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature［J］. J Am Acad Dermatol, 1984,10（6）:1043⁃1060. doi: 10.1016/s0190⁃9622（84）80334⁃5.
［37］	Wysong A, Aasi SZ, Tang JY. Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011［J］. JAMA Dermatol, 2013,149（5）:615⁃616. doi: 10.1001/jamadermatol.2013.3064.
［38］	Rowe DE, Carroll RJ, Day CL Jr. Long⁃term recurrence rates in previously untreated （primary） basal cell carcinoma: implications for patient follow⁃up［J］. J Dermatol Surg Oncol, 1989,15（3）:315⁃328. doi: 10.1111/j.1524⁃4725.1989.tb03166.x.
［39］	Rees JR, Zens MS, Gui J, et al. Non melanoma skin cancer and subsequent cancer risk［J］. PLoS One, 2014,9（6）:e99674. doi: 10.1371/journal.pone.0099674.

[1]	JIANG Wei, SUN Ying, ZHAO Jun-yu, SUN Xiao, SHI Chun-yan, BU Ding-fang, ZHU Xue-jun. Prenatal diagnosis of Hallopeau-Siemens recessive dystrophic epidermolysis bullosa[J]. Chinese Journal of Dermatology, 2006, 39(2): 80 -82 .
[2]	. [J]. Chinese Journal of Dermatology, 2007, 40(9): 579 .
[3]	. [J]. Chinese Journal of Dermatology, 2007, 40(9): 579 -580 .
[4]	. Dynamic observation of paradoxical effect of echinocandins across Candida species in vitro[J]. Chinese Journal of Dermatology, 2012, 45(4): 243 -245 .
[5]	林挺, 周仲平. [J]. Chinese Journal of Dermatology, 2003, 36(8): 460 .
[6]	. [J]. Chinese Journal of Dermatology, 2003, 36(1): 45 -46 .
[7]	. [J]. Chinese Journal of Dermatology, 2001, 34(4): 296 .
[8]	马百芳, 王淑敏, 陈锐, 张爱华. [J]. Chinese Journal of Dermatology, 2001, 30(1): 63 .
[9]	钱江, 陈智, 张闽峰, 江先海, 陈清华. [J]. Chinese Journal of Dermatology, 2000, 33(5): 364 .
[10]	. [J]. Chinese Journal of Dermatology, 1999, 32(4): 279 .

[1]	Hou Xiaoyuan, Wu Nanhui, Xu Mingyuan, Liu Yeqiang. A case of granuloma annulare treated with the JAK inhibitor baricitinib [J]. Chinese Journal of Dermatology, 2024, 57(5): 461-462.
[2]	Chinese Society of Dermatology, China Dermatologist Association, Chinese Association of Integrative Medicine Board of Dermatovenereology. Expert consensus on the clinical application of chemical peeling in China （2024 public version） [J]. Chinese Journal of Dermatology, 2024, 0(5): 20230620-e20230620.
[3]	Writing Committee Expert Group on “Treatment of Extramammary Paget′s Disease: a Chinese Expert Consensus Statement （）”. Treatment of extramammary Paget′s disease: a Chinese expert consensus statement （2024） [J]. Chinese Journal of Dermatology, 2024, 57(5): 400-408.
[4]	China Dermatologist Association. Guidelines for the management of chronic pruritus （2024） [J]. Chinese Journal of Dermatology, 2024, 57(5): 387-399.
[5]	Mycobacteriosis Research Group, China “Belt and Road” Dermatology Alliance, Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy. Expert consensus on the clinical diagnosis and treatment of cutaneous tuberculosis in China （2024） [J]. Chinese Journal of Dermatology, 2024, 57(5): 426-434.
[6]	China Dermatologist Association, Combination of Traditional and Western Medicine Dermatology. Diagnosis and treatment of erythrodermic psoriasis: a Chinese expert consensus statement （2024） [J]. Chinese Journal of Dermatology, 2024, 57(5): 409-417.
[7]	Mycology Group, Combination of Traditional and Western Medicine Dermatology, Chinese Antifungal-Resistant Dermatophytosis Expert Consensus Group. Expert consensus on the diagnosis, treatment, prevention and control of antifungal-resistant dermatophyte infections in China （2024） [J]. Chinese Journal of Dermatology, 2024, 57(5): 418-425.
[8]	Liu Yi, Qu Ying, Lei Wenzhi, Liu Xiaogang, Pan Weihua, Zhang Chao. Clinical efficacy of salt-packing therapy in the treatment of pyogenic granuloma [J]. Chinese Journal of Dermatology, 2024, 0(4): 20230553-e20230553.
[9]	Ju Qiang, Li Jiaqi. Acne vulgaris revisited: from pathogenesis to treatment strategies [J]. Chinese Journal of Dermatology, 2024, 57(4): 289-294.
[10]	Zhang Dimin, Cao Cheng, Zhou Miaoni, Sheng Anqi, Lin Fuquan, Xu Ai′e. Analysis of disease control rate and its influencing factors in patients with progressive non-segmental vitiligo after combined treatment with compound betamethasone injection [J]. Chinese Journal of Dermatology, 2024, 57(4): 350-354.
[11]	Tian Jing, Deng Sisi, Song Zhiqiang . A comparison of clinical characteristics between atopic and non-atopic prurigo nodularis [J]. Chinese Journal of Dermatology, 2024, 57(4): 331-337.
[12]	Wang Yimeng, Wu Wenting, Zhang Qian, Zhang Chunlei, Li Weiwei. Clinical and pathological diagnoses of 389 patients with primary solid tumors localized in the perianal and external genitalia regions [J]. Chinese Journal of Dermatology, 2024, 57(4): 316-323.
[13]	Song Yuqing, Yang Nan, Liu Linlin, Feng Ziyi, Han Shixin, Zhou Meijuan. Dermabrasion for the treatment of familial benign chronic pemphigus: a clinical observation of 6 cases [J]. Chinese Journal of Dermatology, 2024, 0(4): 20220278-e20220278.
[14]	Ge Xinhong, Ma Yingdong, Jiao Yaning, Liu Lingling, Zhou Mei, Zi Wei, Li Bowen. Analysis of efficacy and safety of 532-nm picosecond laser in the treatment of early-stage facial seborrheic keratosis [J]. Chinese Journal of Dermatology, 2024, 57(4): 359-362.
[15]	Yang Yuting, Gu Guolin, Wu Minjuan, Sheng Zhijie, Li Jin, Mo Xingfan, Wu Minzhi, Xu Ping, . Application of serum fibronectin in combination with non-treponemal antibody testing in the exclusion of asymptomatic neurosyphilis among serofast syphilis patients: a preliminary study [J]. Chinese Journal of Dermatology, 2024, 57(3): 246-249.

Expert consensus on diagnosis and treatment of cutaneous basal cell carcinoma （2021）

PDF

Knowledge

Abstract

Cite this article

share this article

References ［39］

Related Articles 15

Metrics

Comments

Recommended 10